Literature DB >> 32099479

External Validation of an Algorithm to Identify Patients with High Data-Completeness in Electronic Health Records for Comparative Effectiveness Research.

Kueiyu Joshua Lin1,2, Gary E Rosenthal3, Shawn N Murphy4,5, Kenneth D Mandl6, Yinzhu Jin1, Robert J Glynn1, Sebastian Schneeweiss1.   

Abstract

OBJECTIVE: Electronic health records (EHR) data-discontinuity, i.e. receiving care outside of a particular EHR system, may cause misclassification of study variables. We aimed to validate an algorithm to identify patients with high EHR data-continuity to reduce such bias.
MATERIALS AND METHODS: We analyzed data from two EHR systems linked with Medicare claims data from 2007 through 2014, one in Massachusetts (MA, n=80,588) and the other in North Carolina (NC, n=33,207). We quantified EHR data-continuity by Mean Proportion of Encounters Captured (MPEC) by the EHR system when compared to complete recording in claims data. The prediction model for MPEC was developed in MA and validated in NC. Stratified by predicted EHR data-continuity, we quantified misclassification of 40 key variables by Mean Standardized Differences (MSD) between the proportions of these variables based on EHR alone vs the linked claims-EHR data.
RESULTS: The mean MPEC was 27% in the MA and 26% in the NC system. The predicted and observed EHR data-continuity was highly correlated (Spearman correlation=0.78 and 0.73, respectively). The misclassification (MSD) of 40 variables in patients of the predicted EHR data-continuity cohort was significantly smaller (44%, 95% CI: 40-48%) than that in the remaining population. DISCUSSION: The comorbidity profiles were similar in patients with high vs low EHR data-continuity. Therefore, restricting an analysis to patients with high EHR data-continuity may reduce information bias while preserving the representativeness of the study cohort.
CONCLUSION: We have successfully validated an algorithm that can identify a high EHR data-continuity cohort representative of the source population.
© 2020 Lin et al.

Entities:  

Keywords:  comparative effectiveness research; continuity; data linkage; electronic medical records; external validation; information bias

Year:  2020        PMID: 32099479      PMCID: PMC7007793          DOI: 10.2147/CLEP.S232540

Source DB:  PubMed          Journal:  Clin Epidemiol        ISSN: 1179-1349            Impact factor:   4.790


  19 in total

Review 1.  Use of health care databases in pharmacoepidemiology.

Authors:  Sean Hennessy
Journal:  Basic Clin Pharmacol Toxicol       Date:  2006-03       Impact factor: 4.080

2.  Building Data Infrastructure to Evaluate and Improve Quality: PCORnet.

Authors:  Douglas A Corley; Heather Spencer Feigelson; Tracy A Lieu; Elizabeth A McGlynn
Journal:  J Oncol Pract       Date:  2015-05       Impact factor: 3.840

3.  Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.

Authors:  Margaret C Fang; Dongjie Fan; Sue Hee Sung; Daniel M Witt; John R Schmelzer; Steven R Steinhubl; Steven H Yale; Alan S Go
Journal:  Med Care       Date:  2017-12       Impact factor: 2.983

Review 4.  A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data.

Authors:  Leonardo Tamariz; Thomas Harkins; Vinit Nair
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

5.  Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population.

Authors:  Peter M Wahl; Keith Rodgers; Sebastian Schneeweiss; Brian F Gage; Javed Butler; Charles Wilmer; Marshall Nash; Gregory Esper; Norman Gitlin; Neal Osborn; Louise J Short; Rhonda L Bohn
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-06       Impact factor: 2.890

6.  Out-of-system Care and Recording of Patient Characteristics Critical for Comparative Effectiveness Research.

Authors:  Kueiyu Joshua Lin; Robert J Glynn; Daniel E Singer; Shawn N Murphy; Joyce Lii; Sebastian Schneeweiss
Journal:  Epidemiology       Date:  2018-05       Impact factor: 4.822

7.  An automated database case definition for serious bleeding related to oral anticoagulant use.

Authors:  Andrew Cunningham; C Michael Stein; Cecilia P Chung; James R Daugherty; Walter E Smalley; Wayne A Ray
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-03-08       Impact factor: 2.890

8.  Building electronic data infrastructure for comparative effectiveness research: accomplishments, lessons learned and future steps.

Authors:  Gurvaneet S Randhawa
Journal:  J Comp Eff Res       Date:  2014-11       Impact factor: 1.744

Review 9.  Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

Authors:  J A P Da Silva; J W G Jacobs; J R Kirwan; M Boers; K G Saag; L B S Inês; E J P de Koning; F Buttgereit; M Cutolo; H Capell; R Rau; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

10.  Biases introduced by filtering electronic health records for patients with "complete data".

Authors:  Griffin M Weber; William G Adams; Elmer V Bernstam; Jonathan P Bickel; Kathe P Fox; Keith Marsolo; Vijay A Raghavan; Alexander Turchin; Xiaobo Zhou; Shawn N Murphy; Kenneth D Mandl
Journal:  J Am Med Inform Assoc       Date:  2017-11-01       Impact factor: 4.497

View more
  8 in total

1.  Impact of longitudinal data-completeness of electronic health record data on risk score misclassification.

Authors:  Yinzhu Jin; Sebastian Schneeweiss; Dave Merola; Kueiyu Joshua Lin
Journal:  J Am Med Inform Assoc       Date:  2022-06-14       Impact factor: 7.942

2.  Longitudinal Data Discontinuity in Electronic Health Records and Consequences for Medication Effectiveness Studies.

Authors:  Kueiyu Joshua Lin; Yinzhu Jin; Joshua Gagne; Robert J Glynn; Shawn N Murphy; Angela Tong; Sebastian Schneeweiss
Journal:  Clin Pharmacol Ther       Date:  2021-09-20       Impact factor: 6.875

3.  Establishing a National Cardiovascular Disease Surveillance System in the United States Using Electronic Health Record Data: Key Strengths and Limitations.

Authors:  Brent A Williams; Stephen Voyce; Stephen Sidney; Véronique L Roger; Timothy B Plante; Sharon Larson; Michael J LaMonte; Darwin R Labarthe; Bailey M DeBarmore; Alexander R Chang; Alanna M Chamberlain; Catherine P Benziger
Journal:  J Am Heart Assoc       Date:  2022-04-12       Impact factor: 6.106

4.  Patient factors associated with new prescribing of potentially inappropriate medications in multimorbid US older adults using multiple medications.

Authors:  Katharina Tabea Jungo; Sven Streit; Julie C Lauffenburger
Journal:  BMC Geriatr       Date:  2021-03-06       Impact factor: 3.921

5.  Continuity and Completeness of Electronic Health Record Data for Patients Treated With Oral Hypoglycemic Agents: Findings From Healthcare Delivery Systems in Taiwan.

Authors:  Chien-Ning Hsu; Kelly Huang; Fang-Ju Lin; Huang-Tz Ou; Ling-Ya Huang; Hsiao-Ching Kuo; Chi-Chuan Wang; Sengwee Toh
Journal:  Front Pharmacol       Date:  2022-04-04       Impact factor: 5.988

6.  A Framework for Visualizing Study Designs and Data Observability in Electronic Health Record Data.

Authors:  Shirley V Wang; Sebastian Schneeweiss
Journal:  Clin Epidemiol       Date:  2022-04-29       Impact factor: 5.814

Review 7.  Creative Approaches for Assessing Long-term Outcomes in Children.

Authors:  Ann Chen Wu; Corina Graif; Shannon Gwin Mitchell; John Meurer; Kenneth D Mandl
Journal:  Pediatrics       Date:  2021-07       Impact factor: 9.703

8.  The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment.

Authors:  Melissa A Haendel; Christopher G Chute; Tellen D Bennett; David A Eichmann; Justin Guinney; Warren A Kibbe; Philip R O Payne; Emily R Pfaff; Peter N Robinson; Joel H Saltz; Heidi Spratt; Christine Suver; John Wilbanks; Adam B Wilcox; Andrew E Williams; Chunlei Wu; Clair Blacketer; Robert L Bradford; James J Cimino; Marshall Clark; Evan W Colmenares; Patricia A Francis; Davera Gabriel; Alexis Graves; Raju Hemadri; Stephanie S Hong; George Hripscak; Dazhi Jiao; Jeffrey G Klann; Kristin Kostka; Adam M Lee; Harold P Lehmann; Lora Lingrey; Robert T Miller; Michele Morris; Shawn N Murphy; Karthik Natarajan; Matvey B Palchuk; Usman Sheikh; Harold Solbrig; Shyam Visweswaran; Anita Walden; Kellie M Walters; Griffin M Weber; Xiaohan Tanner Zhang; Richard L Zhu; Benjamin Amor; Andrew T Girvin; Amin Manna; Nabeel Qureshi; Michael G Kurilla; Sam G Michael; Lili M Portilla; Joni L Rutter; Christopher P Austin; Ken R Gersing
Journal:  J Am Med Inform Assoc       Date:  2021-03-01       Impact factor: 7.942

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.